These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 7800356)

  • 1. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.
    Liu GT; Glaser JS; Schatz NJ; Smith JL
    Ophthalmology; 1994 Nov; 101(11):1779-85. PubMed ID: 7800356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS; Zimmerman B; Kardon RH
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of visual function in patients with biopsy-proven giant cell arteritis.
    Foroozan R; Deramo VA; Buono LM; Jayamanne DG; Sergott RC; Danesh-Meyer H; Savino PJ
    Ophthalmology; 2003 Mar; 110(3):539-42. PubMed ID: 12623817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bane of giant cell arteritis from an ophthalmological viewpoint].
    Meli B; Landau K; Gloor BP
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
    Hayreh SS; Zimmerman B
    Ophthalmology; 2003 Jun; 110(6):1204-15. PubMed ID: 12799248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult giant cell arteritis: ocular manifestations.
    Hayreh SS; Podhajsky PA; Zimmerman B
    Am J Ophthalmol; 1998 Apr; 125(4):521-6. PubMed ID: 9559738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone.
    Cornblath WT; Eggenberger ER
    Ophthalmology; 1997 May; 104(5):854-8. PubMed ID: 9160034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.
    Hwang JM; Girkin CA; Perry JD; Lai JC; Miller NR; Hellmann DB
    Am J Ophthalmol; 1999 Jan; 127(1):102-4. PubMed ID: 9933015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of vision in a 47-year-old man with fulminant giant cell arteritis.
    Postel EA; Pollock SC
    J Clin Neuroophthalmol; 1993 Dec; 13(4):262-70. PubMed ID: 8113439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vision loss in giant cell arteritis: case-based review.
    Kokloni IN; Aligianni SI; Makri O; Daoussis D
    Rheumatol Int; 2022 Oct; 42(10):1855-1862. PubMed ID: 35727336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid management in giant cell arteritis.
    Chan CC; Paine M; O'Day J
    Br J Ophthalmol; 2001 Sep; 85(9):1061-4. PubMed ID: 11520757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy].
    Wenkel H
    Klin Monbl Augenheilkd; 2001 Oct; 218(10):658-61. PubMed ID: 11706381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual loss caused by choroidal ischemia preceding anterior ischemic optic neuropathy in giant cell arteritis.
    Slavin ML; Barondes MJ
    Am J Ophthalmol; 1994 Jan; 117(1):81-6. PubMed ID: 8291597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report].
    Obuchowska I; Mariak Z; Budrowski R
    Klin Oczna; 2006; 108(1-3):124-7. PubMed ID: 16883958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    González-Gay MA; Blanco R; Rodríguez-Valverde V; Martínez-Taboada VM; Delgado-Rodriguez M; Figueroa M; Uriarte E
    Arthritis Rheum; 1998 Aug; 41(8):1497-504. PubMed ID: 9704651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postural vision loss in giant cell arteritis.
    Diego M; Margo CE
    J Neuroophthalmol; 1998 Jun; 18(2):124-6. PubMed ID: 9621270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis.
    Matzkin DC; Slamovits TL; Sachs R; Burde RM
    Ophthalmology; 1992 Jan; 99(1):68-71. PubMed ID: 1741143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual prognosis in extremely old patients with temporal (giant cell) arteritis.
    Liozon E; Loustaud-Ratti V; Ly K; Soria P; Vidal E; Boutros-Toni F; Robert PY
    J Am Geriatr Soc; 2003 May; 51(5):722-3. PubMed ID: 12752855
    [No Abstract]   [Full Text] [Related]  

  • 20. Anterior ischemic optic neuropathy due to giant cell arteritis with normal inflammatory markers.
    Yoeruek E; Szurman P; Tatar O; Weckerle P; Wilhelm H
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):913-5. PubMed ID: 18386041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.